159 related articles for article (PubMed ID: 25585531)
1. Blood methylomic signatures of presymptomatic dementia in elderly subjects with type 2 diabetes mellitus.
Lunnon K; Smith RG; Cooper I; Greenbaum L; Mill J; Beeri MS
Neurobiol Aging; 2015 Mar; 36(3):1600.e1-4. PubMed ID: 25585531
[TBL] [Abstract][Full Text] [Related]
2. Methylomic profiling in trisomy 21 identifies cognition- and Alzheimer's disease-related dysregulation.
Haertle L; Müller T; Lardenoije R; Maierhofer A; Dittrich M; Riemens RJM; Stora S; Roche M; Leber M; Riedel-Heller S; Wagner M; Scherer M; Ravel A; Mircher C; Cieuta-Walti C; Durand S; van de Hove DLA; Hoffmann P; Ramirez A; Haaf T; El Hajj N; Mégarbané A
Clin Epigenetics; 2019 Dec; 11(1):195. PubMed ID: 31843015
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease progression.
Wang Q; Chen Y; Readhead B; Chen K; Su Y; Reiman EM; Dudley JT
Clin Epigenetics; 2020 Dec; 12(1):189. PubMed ID: 33298155
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation markers associated with type 2 diabetes, fasting glucose and HbA
Walaszczyk E; Luijten M; Spijkerman AMW; Bonder MJ; Lutgers HL; Snieder H; Wolffenbuttel BHR; van Vliet-Ostaptchouk JV
Diabetologia; 2018 Feb; 61(2):354-368. PubMed ID: 29164275
[TBL] [Abstract][Full Text] [Related]
5. Association of peripheral blood DNA methylation level with Alzheimer's disease progression.
Li QS; Vasanthakumar A; Davis JW; Idler KB; Nho K; Waring JF; Saykin AJ;
Clin Epigenetics; 2021 Oct; 13(1):191. PubMed ID: 34654479
[TBL] [Abstract][Full Text] [Related]
6. Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study.
Chambers JC; Loh M; Lehne B; Drong A; Kriebel J; Motta V; Wahl S; Elliott HR; Rota F; Scott WR; Zhang W; Tan ST; Campanella G; Chadeau-Hyam M; Yengo L; Richmond RC; Adamowicz-Brice M; Afzal U; Bozaoglu K; Mok ZY; Ng HK; Pattou F; Prokisch H; Rozario MA; Tarantini L; Abbott J; Ala-Korpela M; Albetti B; Ammerpohl O; Bertazzi PA; Blancher C; Caiazzo R; Danesh J; Gaunt TR; de Lusignan S; Gieger C; Illig T; Jha S; Jones S; Jowett J; Kangas AJ; Kasturiratne A; Kato N; Kotea N; Kowlessur S; Pitkäniemi J; Punjabi P; Saleheen D; Schafmayer C; Soininen P; Tai ES; Thorand B; Tuomilehto J; Wickremasinghe AR; Kyrtopoulos SA; Aitman TJ; Herder C; Hampe J; Cauchi S; Relton CL; Froguel P; Soong R; Vineis P; Jarvelin MR; Scott J; Grallert H; Bollati V; Elliott P; McCarthy MI; Kooner JS
Lancet Diabetes Endocrinol; 2015 Jul; 3(7):526-534. PubMed ID: 26095709
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide analysis of DNA methylation in subjects with type 1 diabetes identifies epigenetic modifications associated with proliferative diabetic retinopathy.
Agardh E; Lundstig A; Perfilyev A; Volkov P; Freiburghaus T; Lindholm E; Rönn T; Agardh CD; Ling C
BMC Med; 2015 Aug; 13():182. PubMed ID: 26248552
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide analysis of DNA methylation identifies S100A13 as an epigenetic biomarker in individuals with chronic (≥ 30 years) type 2 diabetes without diabetic retinopathy.
Li T; Xu Y; Shi Y; Chen J; Lin S; Zhu J; Xu X; Lu L; Zou H
Clin Epigenetics; 2020 Jun; 12(1):77. PubMed ID: 32493412
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease-associated (hydroxy)methylomic changes in the brain and blood.
Lardenoije R; Roubroeks JAY; Pishva E; Leber M; Wagner H; Iatrou A; Smith AR; Smith RG; Eijssen LMT; Kleineidam L; Kawalia A; Hoffmann P; Luck T; Riedel-Heller S; Jessen F; Maier W; Wagner M; Hurlemann R; Kenis G; Ali M; Del Sol A; Mastroeni D; Delvaux E; Coleman PD; Mill J; Rutten BPF; Lunnon K; Ramirez A; van den Hove DLA
Clin Epigenetics; 2019 Nov; 11(1):164. PubMed ID: 31775875
[TBL] [Abstract][Full Text] [Related]
10. Artificial intelligence and leukocyte epigenomics: Evaluation and prediction of late-onset Alzheimer's disease.
Bahado-Singh RO; Vishweswaraiah S; Aydas B; Yilmaz A; Metpally RP; Carey DJ; Crist RC; Berrettini WH; Wilson GD; Imam K; Maddens M; Bisgin H; Graham SF; Radhakrishna U
PLoS One; 2021; 16(3):e0248375. PubMed ID: 33788842
[TBL] [Abstract][Full Text] [Related]
11. Whole genome methylation sequencing in blood identifies extensive differential DNA methylation in late-onset dementia due to Alzheimer's disease.
Breen C; Papale LA; Clark LR; Bergmann PE; Madrid A; Asthana S; Johnson SC; Keleş S; Alisch RS; Hogan KJ
Alzheimers Dement; 2024 Feb; 20(2):1050-1062. PubMed ID: 37856321
[TBL] [Abstract][Full Text] [Related]
12. Differential methylation of genes in individuals exposed to maternal diabetes in utero.
Chen P; Piaggi P; Traurig M; Bogardus C; Knowler WC; Baier LJ; Hanson RL
Diabetologia; 2017 Apr; 60(4):645-655. PubMed ID: 28127622
[TBL] [Abstract][Full Text] [Related]
13. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
[TBL] [Abstract][Full Text] [Related]
14. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging.
Jobst KA; Barnetson LP; Shepstone BJ
Int Psychogeriatr; 1998 Sep; 10(3):271-302. PubMed ID: 9785148
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic signatures of methylated DNA cytosine in Alzheimer's disease.
Fetahu IS; Ma D; Rabidou K; Argueta C; Smith M; Liu H; Wu F; Shi YG
Sci Adv; 2019 Aug; 5(8):eaaw2880. PubMed ID: 31489368
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation patterns of LINE-1 and Alu for pre-symptomatic dementia in type 2 diabetes.
Sae-Lee C; Biasi J; Robinson N; Barrow TM; Mathers JC; Koutsidis G; Byun HM
PLoS One; 2020; 15(6):e0234578. PubMed ID: 32525932
[TBL] [Abstract][Full Text] [Related]
17. Is Peripheral BDNF Promoter Methylation a Preclinical Biomarker of Dementia?
Fransquet PD; Ritchie K; Januar V; Saffery R; Ancelin ML; Ryan J
J Alzheimers Dis; 2020; 73(2):645-655. PubMed ID: 31839607
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
[TBL] [Abstract][Full Text] [Related]
19. Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer's disease patients from non-demented subjects.
Nagaraj S; Laskowska-Kaszub K; Dębski KJ; Wojsiat J; Dąbrowski M; Gabryelewicz T; Kuźnicki J; Wojda U
Oncotarget; 2017 Mar; 8(10):16122-16143. PubMed ID: 28179587
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for development of dementia in a unique six-year cohort study. I. An exploratory, pilot study of involvement of the E4 allele of apolipoprotein E, mutations of the hemochromatosis-HFE gene, type 2 diabetes, and stroke.
Percy M; Somerville MJ; Hicks M; Garcia A; Colelli T; Wright E; Kitaygorodsky J; Jiang A; Ho V; Parpia A; Wong MK
J Alzheimers Dis; 2014; 38(4):907-22. PubMed ID: 24081379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
